Literature DB >> 28149900

MicroRNA-499-5p: a therapeutic target in the context of cardiovascular disease.

Menno Hoekstra1.   

Abstract

Entities:  

Year:  2016        PMID: 28149900      PMCID: PMC5233513          DOI: 10.21037/atm.2016.11.61

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  17 in total

1.  Admission levels of circulating miR-499-5p and risk of death in elderly patients after acute non-ST elevation myocardial infarction.

Authors:  Fabiola Olivieri; Roberto Antonicelli; Liana Spazzafumo; Gabriele Santini; Maria Rita Rippo; Roberta Galeazzi; Simona Giovagnetti; Yuri D'Alessandra; Fiorella Marcheselli; Maurizio C Capogrossi; Antonio Domenico Procopio
Journal:  Int J Cardiol       Date:  2014-01-08       Impact factor: 4.164

Review 2.  Extracellular miRNA: A Collision of Two Paradigms.

Authors:  Andrey Turchinovich; Alexander G Tonevitsky; Barbara Burwinkel
Journal:  Trends Biochem Sci       Date:  2016-09-03       Impact factor: 13.807

3.  Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples.

Authors:  Olof Gidlöf; Patrik Andersson; Jesper van der Pals; Matthias Götberg; David Erlinge
Journal:  Cardiology       Date:  2011-06-24       Impact factor: 1.869

4.  The peripheral blood mononuclear cell microRNA signature of coronary artery disease.

Authors:  Menno Hoekstra; Christian A C van der Lans; Bente Halvorsen; Lars Gullestad; Johan Kuiper; Pål Aukrust; Theo J C van Berkel; Erik A L Biessen
Journal:  Biochem Biophys Res Commun       Date:  2010-03-15       Impact factor: 3.575

5.  Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction.

Authors:  Fabiola Olivieri; Roberto Antonicelli; Maria Lorenzi; Yuri D'Alessandra; Raffaella Lazzarini; Gabriele Santini; Liana Spazzafumo; Rosamaria Lisa; Lucia La Sala; Roberta Galeazzi; Rina Recchioni; Roberto Testa; Giulio Pompilio; Maurizio C Capogrossi; Antonio Domenico Procopio
Journal:  Int J Cardiol       Date:  2012-02-12       Impact factor: 4.164

6.  miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI.

Authors:  John F O Sullivan; Antoinette Neylon; Catherine McGorrian; Gavin J Blake
Journal:  Int J Cardiol       Date:  2016-09-13       Impact factor: 4.164

7.  Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1985-11       Impact factor: 4.749

8.  Circulating microRNAs are new and sensitive biomarkers of myocardial infarction.

Authors:  Yuri D'Alessandra; Paolo Devanna; Federica Limana; Stefania Straino; Anna Di Carlo; Paola G Brambilla; Mara Rubino; Maria Cristina Carena; Liana Spazzafumo; Marco De Simone; Barbara Micheli; Paolo Biglioli; Felice Achilli; Fabio Martelli; Stefano Maggiolini; Giancarlo Marenzi; Giulio Pompilio; Maurizio C Capogrossi
Journal:  Eur Heart J       Date:  2010-06-09       Impact factor: 29.983

9.  MiR-499-5p protects cardiomyocytes against ischaemic injury via anti-apoptosis by targeting PDCD4.

Authors:  Yingqing Li; Jianhua Lu; Xueming Bao; Xifu Wang; Junhua Wu; Xiongbin Li; Weiqiang Hong
Journal:  Oncotarget       Date:  2016-06-14

10.  Lin28 promotes transformation and is associated with advanced human malignancies.

Authors:  Srinivas R Viswanathan; John T Powers; William Einhorn; Yujin Hoshida; Tony L Ng; Sara Toffanin; Maureen O'Sullivan; Jun Lu; Letha A Phillips; Victoria L Lockhart; Samar P Shah; Pradeep S Tanwar; Craig H Mermel; Rameen Beroukhim; Mohammad Azam; Jose Teixeira; Matthew Meyerson; Timothy P Hughes; Josep M Llovet; Jerald Radich; Charles G Mullighan; Todd R Golub; Poul H Sorensen; George Q Daley
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

View more
  4 in total

Review 1.  miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure.

Authors:  Marina Sampaio Cruz; Ananília Medeiros Gomes da Silva; Karla Simone Costa de Souza; André Ducati Luchessi; Vivian Nogueira Silbiger
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

2.  Substantially Altered Expression Profile of Diabetes/Cardiovascular/Cerebrovascular Disease Associated microRNAs in Children Descending from Pregnancy Complicated by Gestational Diabetes Mellitus-One of Several Possible Reasons for an Increased Cardiovascular Risk.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Lenka Dvorakova; Ladislav Krofta; Jan Sirc
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

3.  Marathon-Induced Cardiac Strain as Model for the Evaluation of Diagnostic microRNAs for Acute Myocardial Infarction.

Authors:  Omid Shirvani Samani; Johannes Scherr; Elham Kayvanpour; Jan Haas; David H Lehmann; Weng-Tein Gi; Karen S Frese; Rouven Nietsch; Tobias Fehlmann; Steffi Sandke; Tanja Weis; Andreas Keller; Hugo A Katus; Martin Halle; Norbert Frey; Benjamin Meder; Farbod Sedaghat-Hamedani
Journal:  J Clin Med       Date:  2021-12-21       Impact factor: 4.241

4.  Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Lenka Dvorakova; Ladislav Krofta
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.